Dexmedetomidine and Adenosine: Therapeutic Use for SVT

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Supraventricular Tachycardia
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine 2 mcg/kg, Intravenous push

DRUG

Adenosine

Stepwise incremental approach of adenosine starting at 0.2 mg/kg (max 6 mg) followed by 0.3 mg/kg (max 12 mg) if initial dose was unsuccessful

Trial Locations (1)

15224

Childrens Hospital of Pittsburgh of UPMC, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT01495481 - Dexmedetomidine and Adenosine: Therapeutic Use for SVT | Biotech Hunter | Biotech Hunter